News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 13, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Improving Outlook in the U.S. Market is Due to Specialty Product Opportunities and Broader Patient Access with Implementation of the Affordable Care Act and Expansion of Medicaid

Decision Resources Group finds that the outlook for the pharmaceutical market in the United States is becoming more favorable, as the size of the...

Aug 13, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Impact of Genericization in the Unipolar Depression Market Will be Tempered by the Continued Uptake of Novel Antidepressants and Antipsychotics

 Decision Resources Group finds that in the unipolar depression* market, the expanding use of two recently approved...

Aug 12, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Changes Wrought by Affordable Care Act Lead to Surge in Private Exchanges

 Decision Resources Group finds that interest in private exchanges has sharply increased as the Affordable Care Act has gotten officially...

Aug 11, 2014, 16:55 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Asia Pacific Transcatheter Embolization and Occlusion Device Market Will Be Driven By the Adoption of Flow-Diverting Devices and Radioembolization Spheres

 Decision Resources Group finds that the Asia Pacific market for transcatheter embolization and occlusion (TEO) devices—including...

Aug 11, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Imatinib And Sunitinib Will Continue To Dominate Patient Share In The Patient Populations That They Are Approved For Through 2023

 Decision Resources Group finds that the treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through...

Aug 07, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023

 Decision Resources Group finds that the forecast launch of Biogen Idec's Plegridy, Roche/Genentech's ocrelizumab, Biogen Idec/AbbVie's...

Aug 07, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The U.S. Spinal Implant Market Will Grow Modestly to Reach $7.1 Billion by 2022

 Decision Resources Group finds that the United States spinal implant market will expand modestly through 2022 to reach a value of nearly $7.1...

Aug 06, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

High Need for a New Phosphate Binder Exists--Fewer Pills, Better Efficacy in Reducing Phosphorus and Improved Tolerability Rated as Higher Unmet Needs

Decision Resources Group finds that there is a high need for new phosphate binders to treat hyperphosphatemia among surveyed U.S. nephrologists...

Aug 06, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

At One Year Post-Launch, Over Two Thirds of Surveyed U.S. Medical Oncologists Have Prescribed Xofigo to Their Prostate Cancer Patients

Decision Resources Group finds that at one year post-launch in the United States, over two thirds of surveyed U.S. medical oncologists have...

Aug 06, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Driven By Product Innovations, the U.S. Drug Delivery Device Market Will Reach Over $4.5 Billion by 2022

 Decision Resources Group finds that the United States drug delivery device market will grow at a strong rate to reach a value of over $4.5...

Aug 05, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Canadian Peripheral Vascular Device Market Will Only Expand Slightly As Procedure Growth is Largely Offset by Declining Prices

 Decision Resources Group finds that the Canadian market for peripheral vascular (PV) devices will grow slightly through 2022 as procedural...

Aug 04, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed U.S. Rheumatologists' Experience Prescribing Celgene's Otezla at One Month Post Launch Is Less Than 30 Percent But Is Expected to More Than Double Within the Next Month

BURLINGTON, Mass., Aug. 4, 2014 Decision Resources Group finds that at one month post commercial availability, surveyed U.S. rheumatologists have...

Aug 04, 2014, 08:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Seattle Health Systems Launch New Accountable Care Organizations for Employers

 Decision Resources Group finds that University of Washington Medicine (UW Medicine) and Providence Health & Services-Swedish Health...

Jul 31, 2014, 14:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed

 Decision Resources Group's experts are scoping healthcare funding changes brought about by the Affordable Care Act (ACA), which has affected...

Jul 31, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Decision Resources Group Announces First Medical Device Account Targeting Tool in China

 Decision Resources Group is launching an extension of its premier medical technology market intelligence product Marketrack to now...

Jul 30, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake

 Decision Resources Group finds that the majority of surveyed pharmacy and medical directors in the United States believe that the key drivers...

Jul 30, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market

 Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the...

Jul 30, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The U.S. Clot Management Device Market Will Experience Accelerating Growth, Reaching Revenues of $700 Million in 2022

 Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years....

Jul 24, 2014, 14:00 ET
Jul 24, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma

Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United...